We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Haemonetics Corp (HAE) Com Stk USD

Sell:$95.86 Buy:$95.94 Change: $3.54 (3.82%)
Market closed |  Prices as at close on 10 May 2024 | Switch to live prices |
Sell:$95.86
Buy:$95.94
Change: $3.54 (3.82%)
Market closed |  Prices as at close on 10 May 2024 | Switch to live prices |
Sell:$95.86
Buy:$95.94
Change: $3.54 (3.82%)
Market closed |  Prices as at close on 10 May 2024 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Haemonetics Corporation is a global healthcare company. The Company provides a suite of medical products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Its technology addresses three medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. Its segments include Plasma, Blood Center, and Hospital. Its Plasma segment offers automated plasma collection systems, donor management software, and supporting software solutions that improve the donor experience at plasma collection centers. Its Blood Center segment offers a range of solutions that improve donor collection centers' ability to collect and separate blood components for transfusions. Its Hospital segment provides patient care and has four product lines: hemostasis management, vascular closure, cell salvage, and transfusion management. Its portfolio also includes fiber optic sensor technology in the interventional cardiology market.

Contact details

Address:
125 Summer Street
BOSTON
02110
United States
Telephone:
+1 (781) 8487100
Website:
https://www.haemonetics.com

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
HAE
ISIN:
US4050241003
Market cap:
$4.74 billion
Shares in issue:
50.79 million
Sector:
Health Care Supplies
Exchange:
New York Stock Exchange
Country:
United States
Currency:
US dollar
Indices:
n/a

Key personnel

  • Christopher Simon
    President, Chief Executive Officer, Director
  • James D'arecca
    Executive Vice President, Chief Financial Officer
  • Roy Galvin
    President - Global Plasma and Blood Center
  • Stewart Strong
    President - Global Hospital
  • Laurie Miller
    Chief Human Resource Officer, Senior Vice President
  • Anila Lingamneni
    Executive Vice President, Chief Technology Officer
  • Michelle Basil
    Executive Vice President, General Counsel
  • Josep Llorens
    Executive Vice President - Global Manufacturing and Supply Chain

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.